Background: P. mirabilis is a common uropathogenic bacterium that can cause major complications in 34 patients with long-standing indwelling catheters or patients with urinary tract anomalies. In addition, P. 35 mirabilis is a common cause of chronic osteomyelitis in Diabetic foot ulcer (DFU) patients. We isolated 36 P. mirabilis SCDR1 from a Diabetic ulcer patient. We examined P. mirabilis SCDR1 levels of resistance 37 against Nano-silver colloids, the commercial Nano-silver and silver containing bandages and commonly 38 used antibiotics. We utilized next generation sequencing techniques (NGS), bioinformatics, phylogenetic 39 analysis and pathogenomics in the characterization of the infectious pathogen. Results: P. mirabilis 40 SCDR1 is a multi-drug resistant isolate that also showed high levels of resistance against Nano-silver 41 colloids, Nano-silver chitosan composite and the commercially available Nano-silver and silver bandages. 42
Disk diffusion antimicrobial susceptibility testing was performed as described by Matuschek et al. 118 (Matuschek et al. 2014 ). The sterile discs were loaded with different concentrations (50-200 ppm) of 119 colloidal silver nanoparticles solutions and the Nanosilver chitosan composite (composite concentration 120 ranged between 0.1% and 0.01M to 3.2% and 0.16M from chitosan and Silver nitrate respectively) and then 121 placed on Mueller-Hinton (MH) agar plates with bacterial lawns. Within 15 min of application of 122 antimicrobial disks, the plates were inverted and incubated 37 ∘ C for 16 hours. All experiments were done 123 in an aseptic condition in laminar air flow cabinet. After incubation, inhibition zones were read at the point 124 where no apparent growth is detected. The inhibition zone diameters were measured to the nearest 125 millimeter. Similarly, 5mm desks from the commercially available bandages were prepared in an aseptic 126 condition and tested for their antimicrobial activity as described before. 127
Minimum bactericidal (MBC), Minimal inhibitory concertation (MIC) and Biofilm formation tests: 128
MBC and MIC testing were performed as described by Holla et al., (Holla et al. 2012) . Different volumes 129 that contained a range of silver Nanoparticles (50-700 ppm) were delivered to 7.5 ml of Muller-Hinton (MH) broth each inoculated with 0.2 ml of the bacterial suspensions. Within 15 min of application of silver 131 nanoparticles, the tubes were incubated at 37 ∘ C for 16 hours in a shaker incubator at 200 rpm. We included 132 a positive control (tubes containing inoculum and nutrient media without silver nanoparticles) and a 133 negative control (tubes containing silver nanoparticles and nutrient media without inoculum). Biofilm 134 formation ability of P. mirabilis SCDR1 was tested as described before by Yassien and Khardori (Yassien 135 and Khardori 2001). 136
Molecular Genomics analysis: 137

DNA purification and Sequencing: 138
Maxwell 16 automated DNA isolation machine was used for DNA isolation according to the instructions 139 of the manufacturer. Isolated DNA was quantified using NanoDrop 2000c UV-Vis spectrophotometer. The 140 Agilent 2100 Bioanalyzer system will be used for sizing, quantitation and quality control of DNA. The 141 quality of subjected DNA sample was determined by loading a 150 mg of diluted DNA in 1% agarose E-142 gel (Invitrogen, Paisley, UK). We have conducted two sequencing runs using the Personal Genome 143 Machine (PGM) sequencer from Life Technologies (Thermo Fischer) according to the instructions of the 144 manufacture. 145
Bioinformatics analysis: 146
We have developed an analysis pipeline to identify the suggested pathogen and annotate it. First, 147 the quality of the reads was assessed and reads with a quality score less than 20bp were trimmed out. The 148 reads were then passed to the program Metaphlan (Segata et al. 2012 ) for primary identifications of 149 microbial families included in the samples based on unique and clade-specific marker genes. In parallel to 150 run Metaphlan analysis, we used BLAST program to map each read to the non-redundant nucleotide 151 database of NCBI. We mapped the reads back to the bacterial genomes thought to be the pathogen; these 152 are the top ranked bacteria based on Metaphlan, BLAST results, and related taxa analysis. The integration 153 of the different tools and execution of the whole pipeline is achieved through python scripts developed in-154 house. A version of this pipeline is currently being imported to the workflow system Tavaxy (Abouelhoda 155 et al. 2012 ) to be used by other researchers. Furthermore, we retrieved the genome annotation from the Genbank and investigated the missing genes. In addition, we used QIIME the open-source bioinformatics 157 pipeline for performing microbiome analysis from raw DNA sequencing data for taxonomic assignment 158 and results visualizations (Caporaso et al. 2010) . 159
Phylogenetic analysis 160
The 16S rDNA sequences of our isolate were used to construct a phylogenetic relationship with 161 other Proteus mirabilis species. We acquired partial 16S rDNA sequences of selected Proteus mirabilis 162 species from the GenBank. In order to establish the phylogenetic relationships among taxa, phylogenetic 163 trees were constructed using the Maximum Likelihood (ML) method based on the Jukes-Cantor model the 164 best fit to the data according to AIC criterion (Tamura and Nei 1993 Furthermore, Table 2 shows the resistance of P. mirabilis SCDR1 against colloidal Nanosilver assessed by 231 minimal inhibitory concentration method compared with other tested Gram positive and negative bacterial 232 species. Once more, P. mirabilis SCDR1 showed high resistance against the gradually increased 233 concentrations of colloidal Nano-Silver. We observed P. mirabilis SCDR1 bacterial growth to colloidal 234 Nanosilver concentration up to 500 ppm. On the other hand, K. pneumoniae showed the highest sensitivity 235 against silver nanoparticles with no observed growth at only 100 ppm colloidal Nanosilver concentration. 236
In addition, both E. coli and P. aeruginosa showed the high sensitivity against silver nanoparticles with no 237 observed growth at 150 ppm colloidal Nanosilver concentration. While, S. aureus tolerated only 200 ppm 238 colloidal Nanosilver concentration. 239
Similarly, Table 3 shows the resistance of P. mirabilis SCDR1 against silver and Nanosilver composite 240 assessed by disk diffusion method. Nanosilver chitosan composites, with concentration, ranged between 241 0.1% and 0.01M to 3.2% and 0.16M from chitosan and Silver nitrate respectively, had a comparable killing 242 effect on both Gram positive and negative bacterial namely, S. aureus and P. aeruginosa. While none of 243 the tested Nanosilver chitosan composites had any killing effect on P. mirabilis SCDR1. Similarly, all the 244 tested commercially available silver and Nanosilver containing wound dressing bandages showed the 245 enhanced killing effect on both S. aureus and P. aeruginosa. However, all these wound dressing bandages 246 failed to inhibit P. mirabilis SCDR1 growth. P. mirabilis SCDR1 was able to produce strong biofilm with 247 OD of 0.296. 248 
General genome features. 254
Data from our draft genome of P. mirabilis SCDR1 was deposited in the NCBI-GenBank and was assigned 255 accession number LUFT00000000. The P. mirabilis SCDR1 assembly resulted in 63 contigs, with an N50 256 contig size of 227,512 bp nucleotides, and a total length of 3,815,621 bp. The average G+C content 257 was 38.44%. Contigs were annotated using the Prokaryotic Genomes Automatic Annotation Pipeline 258 (PGAAP) available at NCBI (http://www.ncbi.nlm.nih.gov/) providing a total of 3,533 genes, 3,414 coding 259 DNA sequence genes, 11, 10, 18 rRNAs (5S, 16S, and 23S), and 76 tRNAs. On the other hand, the 260 bacterial bioinformatics database and analysis resource (PATRIC) gene annotation analysis showed that 261 the number of the observed coding sequence (CDS) is 4423, rRNA is 10 and tRNA is 71. The unique gene 262 count for the different observed metabolic pathways is 2585 (Figure 1) . 263 Carbohydrate metabolism pathways maintained the highest number of dedicated unique gene count (477) 266 while signal transduction pathways maintained the highest number (5). In addition, biosynthesis of 267 secondary metabolites, such as tetracycline, Streptomycin, Novobiocin, and Betalain, maintained a high 268 number of dedicated unique gene (308). It is also noteworthy that Xenobiotics Biodegradation and 269
Metabolism pathways also maintained a high number of dedicated unique gene (245) (Supplementary 270 table 1 and 2). 271
Pathogen identification and phylogenetic analysis. 272
As stated before biochemical identification of the isolate confirmed the identity of our isolate to be 273 belonging to Proteus mirabilis species. Moreover, Primary analysis of Metaphlan showed that Proteus 274 mirabilis is the most dominant species in the sample (Figure 2) . The appearance of other bacterial species 275 in the Metaphlan diagram is explained by genomic homology similarity of other bacteria to Proteus 276 mirabilis. P. mirabilis SCDR1 genome showed high similarly 92.07% to the genome of P. mirabilis strain 277 BB2000 followed by P. mirabilis strain C05028 (90.99%) and P. mirabilis strain PR03 (89.73%) ( Table  278   4 
). 279
A similar scenario was observed when constructing the phylogenetic relationship between our isolate and 280
other Proteus mirabilis available in the NCBI-GenBank. 16Sr DNA-based maximum likelihood 281 phylogenetic tree (Figure 3) showed that our isolate is located within a large clade that contains the majority 282 of Proteus mirabilis strains and isolates. In addition, P. mirabilis SCDR1 showed to be closely related to 283 the reference strain P. mirabilis HI4320 compared with P. mirabilis BB2000 that is located in another clade 284 of four Proteus mirabilis taxa. On the contrary, whole genome Neighbor-joining phylogenetic tree of 285
Proteus mirabilis spices including P. mirabilis SCDR1 isolate (Figure 4) , showed that our isolate is more 286 closely related to P. mirabilis BB2000 compared with the reference strain/genome P. mirabilis HI4320. 287
However, Figure 4 showed that P. mirabilis SCDR1 exhibited obvious genetic divergence from other 288
Proteus mirabilis species. Similar results were observed when performing pairwise pair-wise whole 289 genome alignment of P. mirabilis strain SCDR1 against reference genomes ( Figure 5 ). 290 
299
This was also confirmed with the clear divergence among P. mirabilis SCDR1 Proteus mirabilis species 300 on the proteomic level (Figure 6 ). Comparing annotated proteins across genomes showed that the majority 301 of protein sequence identity ranged between 95-99.5% with the highest values (100%) was observed for 302 ribosomal proteins such as, SSU ribosomal protein S10p (S20e), LSU ribosomal protein L3p (L3e), LSU 
337
Bacterial pathogenic and virulence factors 338
Pathogenomics analysis using PathogenFinder 1.1 showed that our input organism was predicted as a 339 human pathogen, Probability of being a human pathogen 0.857. P. mirabilis SCDR1 comparative proteome 340 analysis showed 35 matched hits from pathogenic families and only one hit from non-pathogenic families 341
( Supplementary Table 3 ). In addition, genome analysis showed that P. mirabilis SCDR1 isolate contains 342 numerous virulence factor genes and/or operons that marques it to be a virulent pathogenic bacterium. 343
These virulence factors include Swarming behavior, mobility (flagellae), adherence, toxin and hemolysin 344 production, Urease, Quorum sensing, iron acquisition systems, proteins that function in immune evasion, 345 cell invasion and biofilm formation, stress tolerance factors, and chemotaxis related factors 346
( Supplementary Table 4 ). 347
Proteus mirabilis SCDR1 Resistome: 348
Antibiotic resistance: 349
Antibiotic resistance identification Perfect and Strict analysis using Resistance Gene Identifier 350 (RGI) showed that P. mirabilis SCDR1 isolate contains 34 antibiotic resistance genes that serve in 21 351 antibiotic resistance functional categories (Supplementary Table 5 and Figure 7) . Table 5 displays genes/proteins were detected, namely, copA, copB, copC, copD, cueO, cueR, cutC, cutF and 363
CuRO_2_CopA_like1. In addition, gene determinants of Copper/silver efflux system were also observed, 364 namely, oprB, oprM and cusC_1. Moreover, several heavy metal resistance proteins and efflux systems 365
were also observed such as magnesium/cobalt efflux protein CorC, metal resistance proteins (AGS59089.1, 366 AGS59090.1 and AGS59091.1), nickel-cobalt-cadmium resistance protein NccB, arsenical pump 367 membrane protein (ArsB permease), Lead, cadmium, zinc and mercury transporting ATPase, outer 368 membrane component of tripartite multidrug resistance system (CusC) and complete P. mirabilis tellurite 369 resistance loci (terB, terA, terC, terD, terE, terZ). Furthermore, enzymes involved in heavy metal resistance 370
were also observed such as Glutathione S-transferase (gst1, gst, Delta and Uncharacterized), arsenite S-371 adenosylmethyltransferase (Methyltransferase type 11) and alkylmercury lyase (MerB). 
